Back to Journals » Drug Design, Development and Therapy » Advances in p53 Drug Discovery
Drug Design, Development and Therapy
- View all (5535)
- Volume 20, 2026 (304)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Journal Articles:
- Modern Computational Approaches for Drug Design and Discovery (3)
- Advances in p53 Drug Discovery (4)
- Nanotechnology in Drug Delivery for Neurodegenerative Diseases (2)
- New Trends in Formulations for Oral Inhalation (1)
- Exploring Fragment-Based Approaches in Drug Discovery (2)
- Advances in design and development of ophthalmic drugs (9)
- Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs (4)
- Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System (1)
- A cross-sectional survey on heart failure from China: disease burden and management (3)
- Ten Years of Biosimilars in Europe (4)
Advances in p53 Drug Discovery
Often referred to as the "guardian of the genome", p53 plays an important role in maintaining cellular homeostasis by regulating and orchestrating cell cycle arrest, DNA repair, apoptosis, and senescence. Mutations in the TP53 gene which encodes p53, are found in a broad range of human cancers, leading to loss of its tumor-suppressive functions and contributing to cancer progression and metastasis. To help raise the profile of this important area of research, Drug Design, Development and Therapy is publishing a timely Article Collection on p53 drug discovery.
Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats
Almalki RS
Drug Design, Development and Therapy 2026, 20:570825
Published Date: 4 March 2026
Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4
Vaas S, Zimmermann MO, Klett T, Boeckler FM
Drug Design, Development and Therapy 2023, 17:1247-1274
Published Date: 25 April 2023
Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP
Ernst LN, Jaag SJ, Wydra VR, Masberg B, Knappe C, Gerstenecker S, Serafim RAM, Liang XJ, Seidler NJ, Lämmerhofer M, Gehringer M, Boeckler FM
Drug Design, Development and Therapy 2025, 19:2253-2284
Published Date: 25 March 2025
Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53
Klett T, Schwer M, Ernst LN, Engelhardt MU, Jaag SJ, Masberg B, Knappe C, Lämmerhofer M, Gehringer M, Boeckler FM
Drug Design, Development and Therapy 2024, 18:2653-2679
Published Date: 1 July 2024
